These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11840901)

  • 1. Medicaid patients in a private health maintenance organization: patterns of chemical dependency treatment.
    Walter LJ; Parthasarathy S; Allen S; Ackerson L
    J Behav Health Serv Res; 2002 Feb; 29(1):1-14. PubMed ID: 11840901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance abuse treatment duration for Medicaid versus commercial clients in a health maintenance organization.
    McFarland BH; Lynch FL; Freeborn DK; Green CA; Polen MR; Deck DD; Dickinson DM
    Med Care; 2006 Jun; 44(6):601-6. PubMed ID: 16708010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicaid chemical dependency patients in a commercial health plan: do high medical costs come down over time?
    Walter LJ; Ackerson L; Allen S
    J Behav Health Serv Res; 2005; 32(3):253-63. PubMed ID: 16010182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of health care experiences for medicaid and commercially enrolled children in a large, nonprofit health maintenance organization.
    Newacheck PW; Lieu T; Kalkbrenner AE; Chi FW; Ray GT; Cohen JW; Weinick RM
    Ambul Pediatr; 2001; 1(1):28-35. PubMed ID: 11888369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program.
    Green CA; Polen MR; Dickinson DM; Lynch FL; Bennett MD
    J Subst Abuse Treat; 2002 Dec; 23(4):285-95. PubMed ID: 12495790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of health sector market factors and vulnerable group membership on access to alcohol, drug, and mental health care.
    Stockdale SE; Tang L; Zhang L; Belin TR; Wells KB
    Health Serv Res; 2007 Jun; 42(3 Pt 1):1020-41. PubMed ID: 17489902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serving distinct populations: performance in Medicaid HMOs and commercial HMOs.
    Terman J; Lee KH
    Health Care Manag (Frederick); 2011; 30(4):301-12. PubMed ID: 22042137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case study: a medicaid health maintenance organization quality initiative for behavioral health.
    Chang G; Wilcox M
    Am J Med Qual; 2005; 20(2):98-103. PubMed ID: 15851388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicaid managed care: the last bastion of the HMO?
    Draper DA; Hurley RE; Short AC
    Health Aff (Millwood); 2004; 23(2):155-67. PubMed ID: 15046139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of low income among childbearing women in California: implications for the private and public sectors.
    Braveman P; Egerter S; Marchi K
    Am J Public Health; 1999 Jun; 89(6):868-74. PubMed ID: 10358677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to substance abuse treatment services under the Oregon Health Plan.
    Deck DD; McFarland BH; Titus JM; Laws KE; Gabriel RM
    JAMA; 2000 Oct; 284(16):2093-9. PubMed ID: 11042758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicaid beneficiaries' experiences in HMO and fee-for-service health care.
    Piña DL
    J Health Care Poor Underserved; 1998 Nov; 9(4):433-48. PubMed ID: 10073218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing Medicaid behavioral health care: findings of a national survey in the year 2000.
    Ridgely MS; Maglione MA
    Psychiatr Serv; 2006 Jul; 57(7):1000-6. PubMed ID: 16816285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health risk factor surveys of commercial plan- and Medicaid-enrolled members of health-maintenance organizations--Michigan, 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Oct; 46(39):923-6. PubMed ID: 9347906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of fortune: commercial HMOs in the Medicaid market.
    McCue MJ; Hurley RE; Draper DA; Jurgensen M
    Health Aff (Millwood); 1999; 18(1):223-30. PubMed ID: 9926659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is conventional wisdom wrong? Coverage for substance abuse treatment under Medicaid managed care.
    Maglione M; Ridgely MS
    J Subst Abuse Treat; 2006 Jun; 30(4):285-90. PubMed ID: 16716842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Southern California Kaiser-Permanente Chemical Dependency Recovery Program evaluation: results of a treatment outcome study in an HMO setting.
    Ershoff D; Radcliffe A; Gregory M
    J Addict Dis; 1996; 15(3):1-25. PubMed ID: 8842847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cost-containment policies on rates of coronary revascularization in California.
    Langa KM; Sussman EJ
    N Engl J Med; 1993 Dec; 329(24):1784-9. PubMed ID: 8232488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health care factors related to stage at diagnosis and survival among Medicare patients with colorectal cancer.
    Lee-Feldstein A; Feldstein PJ; Buchmueller T
    Med Care; 2002 May; 40(5):362-74. PubMed ID: 11961471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.